Form 4: Nexalin Directors Sell Warrants Ahead of Expiration

Nexalin Technology directors Marilyn Elson and Leonard Osser reported the disposition of 23,150 common stock warrants just nine days before their expiration.

Summary

• Marilyn Elson and Leonard Osser, both directors and 10% owners of Nexalin Technology, Inc. (NXL), reported a transaction involving derivative securities.
• The transaction, dated September 10, 2025, involved the disposition (sale) of 23,150 common stock warrants.
• These warrants had an exercise price of $4.15 and were sold at a price of $0.0174 per warrant.
• The warrants were exercisable from September 19, 2022, and were set to expire on September 19, 2025.
• Following this transaction, the reporting persons beneficially own 112,850 derivative securities (warrants).
• The filing notes that Marilyn Elson owns shares with her spouse, Leonard Osser, and they share voting and dispositive power, filing this Form 4 jointly.

Sentiment

Score: 3

Explanation: The insider sale of out-of-the-money warrants just before their expiration is generally perceived as a negative signal, indicating a lack of confidence in the stock's ability to reach the exercise price or a move to realize minimal value before expiration.

Negatives

• Directors Marilyn Elson and Leonard Osser disposed of 23,150 common stock warrants just nine days before their expiration date of September 19, 2025.
• The warrants were sold at a price of $0.0174 per warrant, significantly below their exercise price of $4.15, indicating they were likely out-of-the-money at the time of sale.
• This insider selling, particularly of out-of-the-money warrants close to expiration, could be interpreted as a lack of confidence in the stock reaching the exercise price before the warrants expire.

Risks

• Potential investor concern regarding insider sentiment due to the disposition of derivative securities, especially warrants sold close to expiration and significantly below their exercise price.

Future Outlook

No explicit future outlook or guidance is provided in this Form 4 filing.

Industry Context

This Form 4 filing is specific to Nexalin Technology, Inc. and its insiders, and does not provide broader industry trends or competitive analysis.

Stakeholder Impact

• Shareholders: May interpret the insider sale as a negative signal regarding future stock performance or management's confidence in the company's near-term prospects.

Key Dates

Recommendation

The disposition of warrants by directors, particularly at a low price relative to the exercise price and close to expiration, suggests a lack of confidence in the warrants' value or a decision to monetize them before they expire worthless. However, without broader financial context or other strategic updates, a definitive 'sell' recommendation is premature. Investors should 'hold' and monitor future filings and company performance for a clearer picture.

Keywords

Nexalin Technology, NXL, Form 4, insider trading, warrant sale, director transaction, beneficial ownership, derivative securities